Chemoinformaics analysis of (+)-S-methyl-L-cysteine sulfoxide (MCSO)
| Molecular Weight | 151.187 | nRot | 3 |
| Heavy Atom Molecular Weight | 142.115 | nRig | 1 |
| Exact Molecular Weight | 151.03 | nRing | 0 |
| Solubility: LogS | -0.193 | nHRing | 0 |
| Solubility: LogP | -2.871 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 19.0871 |
| nHD | 1 | BPOL | 14.1829 |
| QED | 0.447 |
| Synth | 5.652 |
| Natural Product Likeliness | 0.316 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.969 |
| HIA | 0.021 |
| CACO-2 | -5.406 |
| MDCK | 0.00132493 |
| BBB | 0.297 |
| PPB | 0.101738 |
| VDSS | 0.675 |
| FU | 0.917575 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.062 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.598 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.155 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.024 |
| CL | 2.26 |
| T12 | 0.836 |
| hERG | 0.015 |
| Ames | 0.018 |
| ROA | 0.035 |
| SkinSen | 0.161 |
| Carcinogencity | 0.807 |
| EI | 0.158 |
| Respiratory | 0.173 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.948917 |